J. B. Chemicals & Pharmaceuticals Limited (NSE: JBCHEPHARM)
India flag India · Delayed Price · Currency is INR
1,882.55
+28.50 (1.54%)
Oct 30, 2024, 3:29 PM IST

JBCHEPHARM Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Jun '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019 - 2015
Revenue
35,92434,84231,49324,24220,42517,747
Upgrade
Revenue Growth (YoY)
10.17%10.63%29.91%18.69%15.09%8.00%
Upgrade
Cost of Revenue
12,44012,14211,9638,6557,2276,525
Upgrade
Gross Profit
23,48422,70019,53015,58813,19811,222
Upgrade
Selling, General & Admin
8,2938,1117,2785,6624,2584,068
Upgrade
Other Operating Expenses
5,7815,6615,1904,4603,3583,308
Upgrade
Operating Expenses
15,55215,15613,61210,8498,3038,040
Upgrade
Operating Income
7,9337,5445,9184,7394,8953,182
Upgrade
Interest Expense
-372.32-436.52-347.68-40.85-67.43-29.17
Upgrade
Interest & Investment Income
44.2644.2625.399.3917.7941.01
Upgrade
Currency Exchange Gain (Loss)
44.0744.07-110.87-38.0142.34-67.37
Upgrade
Other Non Operating Income (Expenses)
-3.19-5.79-2.791.0650.8864.44
Upgrade
EBT Excluding Unusual Items
7,6457,1905,4824,6714,9393,191
Upgrade
Gain (Loss) on Sale of Investments
327.43327.4369350.43505.5379.97
Upgrade
Gain (Loss) on Sale of Assets
-2.32-2.320.0724.05524.3717.88
Upgrade
Legal Settlements
------100
Upgrade
Other Unusual Items
--1.283.98--
Upgrade
Pretax Income
7,9707,5155,5525,0495,9693,489
Upgrade
Income Tax Expense
2,0991,9891,4521,1891,484765
Upgrade
Earnings From Continuing Operations
5,8715,5264,1003,8604,4852,724
Upgrade
Minority Interest in Earnings
---1.7-6.82-5.59-3.45
Upgrade
Net Income
5,8715,5264,0983,8544,4802,720
Upgrade
Net Income to Common
5,8715,5264,0983,8544,4802,720
Upgrade
Net Income Growth
31.31%34.84%6.35%-13.98%64.66%40.62%
Upgrade
Shares Outstanding (Basic)
155155155155155159
Upgrade
Shares Outstanding (Diluted)
159159157155155159
Upgrade
Shares Change (YoY)
1.18%1.26%1.23%0.09%-2.86%-3.21%
Upgrade
EPS (Basic)
37.8635.6626.5024.9328.9817.10
Upgrade
EPS (Diluted)
36.9434.8526.1724.9128.9817.10
Upgrade
EPS Growth
29.78%33.17%5.06%-14.04%69.50%45.27%
Upgrade
Free Cash Flow
-6,6295,5621,0732,6702,028
Upgrade
Free Cash Flow Per Share
-41.8035.516.9317.2812.74
Upgrade
Dividend Per Share
-12.2508.8758.2508.2505.500
Upgrade
Dividend Growth
-38.03%7.58%0%50.00%120.00%
Upgrade
Gross Margin
65.37%65.15%62.01%64.30%64.62%63.23%
Upgrade
Operating Margin
22.08%21.65%18.79%19.55%23.97%17.93%
Upgrade
Profit Margin
16.34%15.86%13.01%15.90%21.93%15.33%
Upgrade
Free Cash Flow Margin
-19.03%17.66%4.42%13.07%11.43%
Upgrade
EBITDA
9,3438,8967,0385,3845,4983,757
Upgrade
EBITDA Margin
26.01%25.53%22.35%22.21%26.92%21.17%
Upgrade
D&A For EBITDA
1,4101,3521,120645.45602.84575.13
Upgrade
EBIT
7,9337,5445,9184,7394,8953,182
Upgrade
EBIT Margin
22.08%21.65%18.79%19.55%23.97%17.93%
Upgrade
Effective Tax Rate
26.34%26.46%26.16%23.54%24.86%21.93%
Upgrade
Revenue as Reported
36,29935,21431,59224,63521,54918,254
Upgrade
Advertising Expenses
-2,0771,8081,250838.21826.56
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.